The principals of Bohemica Pharmaceuticals LLC are exploring polymers and nanoparticles for delivery of drugs and nucleic acids. A particular area of focus is pharmacologically active polymers (polymeric drugs) and in delivery vectors suitable for delivery of drug/gene, drug/siRNA, and drug/miRNA combinations in the treatment of metastatic cancer and inflammatory bowel disease.